Pratt Collard Advisory Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Pratt Collard Advisory Partners's NVS Position: Q1 2018 in Review
Pratt Collard Advisory Partners sold out of Novartis (NVS) in Q1 2018, closing a stake of 2,675 shares — an estimated $201K sold.
Pratt Collard Advisory Partners first reported a position in NVS in Q4 2017 and held it in 1 quarter. The position peaked at $201K in Q4 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.
- Pratt Collard Advisory Partners reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
- Pratt Collard Advisory Partners sold 2,675 Novartis shares in Q1 2018, an estimated $201K.
- Pratt Collard Advisory Partners first reported a position in Novartis in Q4 2017 and held it in 1 quarter.
- Pratt Collard Advisory Partners's Novartis position peaked at $201K in Q4 2017.
- 1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.
Based on Pratt Collard Advisory Partners's 13F filing for Q1 2018, filed 20 Apr 2018.